Is AQST or ASRT more undervalued in 2026?

CirclFi compares Aquestive Therapeutics, Inc. (AQST) and Assertio Holdings, Inc. (ASRT) using 13 institutional-grade valuation models. AQST has a Quality of Company score of 5.7/10 while ASRT scores 5.4/10.

Which is a better buy — AQST or ASRT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AQST and ASRT valuations compare?

AQST at $4.02 and ASRT at $23.44 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AQST vs ASRT Valuation Comparison 2026 — Intrinsic Value Analysis

AQST

Drug Manufacturers - Specialty & Generic

Aquestive Therapeutics, Inc.

Quality

5.7

out of 10

Value Trap

LOW

Price

$4.02

Last close

Models

10/13

Active

ASRT

Drug Manufacturers - Specialty & Generic

Assertio Holdings, Inc.

Quality

5.4

out of 10

Value Trap

SAFE

Price

$23.44

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	AQST Fair Value	AQST Upside	ASRT Fair Value	ASRT Upside
Bayesian DCF	Intrinsic	$1.37	-66.0%	$50.65	+116.1%
Earnings Power Value	Intrinsic	$1.22	-70.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$0.86	-79.7%	$76.95	+228.3%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AQST vs ASRT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AQST vs ASRT — Which Stock Is More Undervalued?

AQST scores higher with a 5.7/10 quality rating vs ASRT's 5.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aquestive Therapeutics, Inc. (AQST) and Assertio Holdings, Inc. (ASRT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AQST currently trades at $4.02 with a QOC of 5.7/10, while ASRT trades at $23.44 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).